Page last updated: 2024-10-24

calmidazolium and Protein Aggregation, Pathological

calmidazolium has been researched along with Protein Aggregation, Pathological in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Singh, V1
Deepak, RNVK1
Sengupta, B1
Joshi, AS1
Fan, H1
Sen, P1
Thakur, AK1

Other Studies

1 other study available for calmidazolium and Protein Aggregation, Pathological

ArticleYear
Calmidazolium Chloride and Its Complex with Serum Albumin Prevent Huntingtin Exon1 Aggregation.
    Molecular pharmaceutics, 2018, 08-06, Volume: 15, Issue:8

    Topics: Animals; Biological Assay; Cell Line; Huntingtin Protein; Huntington Disease; Imidazoles; Mice; Mole

2018